PNPLA3 and metabolic dysfunction-associated steatotic liver disease: Conversely, the hypermethylation of CpG99 in the regulatory region of PNPLA3 and the subsequent suppression of PNPLA3 mRNA levels were observed in the livers of patients with NAFLD in advanced stages of fibrosis.